Gapping up
In reaction to strong earnings/guidance:
- BAC +1.0%
M&A news:
- ERI +7.3% (to acquire Tropicana Entertainment (TPCA) in a cash transaction that is valued at $1.85 bln)
- IEP +1.7% (confirms agreement to sell Tropicana's real estate to Gaming and Leisure Properties)
Other news:
- ALKS +18.7% (announces that the FDA has accepted for review the NDA for ALKS 5461)
- ACRX +8.9% (announced the successful completion of the human factors (HF) study performed to validate the effectiveness of the revised DSUVIA directions for use)
- IDRA +4.3% (enters into a clinical development support agreement with Pillar Partners Foundation)
- ALNY +3.6% (presents new clinical results for Givosiran)
- INFY +2.9% (rebounding following Friday's post earnings decline)
- SHPG +2.5% (announces sale of oncology business to Servier for $2.4 bln)
- JD +0.8% (clarifies potential confusion caused by certain statements made by CEO Richard Qiangdong Liu in a recent event)
- GOOG +0.6% (positive article from Barrons), .
Analyst comments:
- ULTA +2.3% (upgraded to Buy from Neutral at Guggenheim)
- BCS +2% (upgraded to Buy from Hold at Jefferies)
- COST +1.2% (upgraded to Outperform from Market Perform at Wells Fargo)
- AWK +0.7% (upgraded to Buy from Neutral at Janney)